{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:04:28Z","timestamp":1785323068138,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81660443"],"award-info":[{"award-number":["81660443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["20192BCBL23025"],"award-info":[{"award-number":["20192BCBL23025"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004637","name":"Nanchang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019078","name":"Outstanding Young Talents Funding of Jiangxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019078","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020205","name":"Health Commission of Jiangxi Province","doi-asserted-by":"publisher","award":["2017A007"],"award-info":[{"award-number":["2017A007"]}],"id":[{"id":"10.13039\/501100020205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Histochemica"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.acthis.2025.152249","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T05:15:39Z","timestamp":1742706939000},"page":"152249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Silencing Livin gene expression by RNA interference enhanced the chemotherapeutic sensitivity of drug-resistant osteosarcoma cells to doxorubicin"],"prefix":"10.1016","volume":"127","author":[{"given":"Lei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaimin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.acthis.2025.152249_bib1","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1158\/2159-8290.CD-20-1638","article-title":"Overcoming resistance to tumor-targeted and immune-targeted therapies","volume":"11","author":"Aldea","year":"2021","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.acthis.2025.152249_bib2","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.18632\/oncotarget.14067","article-title":"Livin\/BIRC7 expression as malignancy marker in adrenocortical tumors","volume":"8","author":"Altieri","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.acthis.2025.152249_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7150\/jca.49641","article-title":"MUC 15 promotes osteosarcoma cell proliferation, migration and invasion through livin, MMP-2\/MMP-9 and Wnt\/\u03b2-catenin signal pathway","volume":"12","author":"Chen","year":"2021","journal-title":"J. Cancer"},{"issue":"6","key":"10.1016\/j.acthis.2025.152249_bib4","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1158\/1078-0432.CCR-16-2172","article-title":"Therapeutic small molecules target inhibitor of apoptosis proteins in cancers with deregulation of extrinsic and intrinsic cell death pathways","volume":"23","author":"Derakhshan","year":"2017","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"1","key":"10.1016\/j.acthis.2025.152249_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100283","article-title":"Osteosarcomas with few chromosomal alterations or adult onset are genetically heterogeneous","volume":"104","author":"Difilippo","year":"2024","journal-title":"Lab Invest."},{"issue":"1","key":"10.1016\/j.acthis.2025.152249_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4149\/neo_2019_190106N18","article-title":"MiR-512-3p regulates malignant tumor behavior and multi-drug resistance in breast cancer cells via targeting Livin","volume":"67","author":"Duan","year":"2020","journal-title":"Neoplasma"},{"issue":"1","key":"10.1016\/j.acthis.2025.152249_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s43141-021-00244-w","article-title":"Livin\/BIRC7 gene expression as a possible diagnostic biomarker for endometrial hyperplasia and carcinoma","volume":"19","author":"Elmekkawy","year":"2021","journal-title":"J., Genet. Eng. Biotechnol."},{"issue":"1","key":"10.1016\/j.acthis.2025.152249_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245581","article-title":"Prognostic significance of BIRC7\/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin","volume":"16","author":"Faruk","year":"2021","journal-title":"PloS One"},{"issue":"28","key":"10.1016\/j.acthis.2025.152249_bib9","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1200\/JCO.2014.56.8741","article-title":"Targeting inhibitor of apoptosis proteins for cancer therapy: a double-edge sword?","volume":"32","author":"Fulda","year":"2014","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.acthis.2025.152249_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21134659","article-title":"Pharmacogenomics and pharmacogenetics in osteosarcoma: translational studies and clinical impact","volume":"21","author":"Hattinger","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.acthis.2025.152249_bib11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3389\/fneur.2017.00474","article-title":"Difference in the inhibitory effect of temozolomide on TJ905 glioma cells and stem cells","volume":"8","author":"Jin","year":"2017","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.acthis.2025.152249_bib12","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.7969","article-title":"Inhibitor of apoptosis protein Livin promotes tumor progression and chemoradioresistance in human anaplastic thyroid cancer","volume":"45","author":"Kim","year":"2021","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.acthis.2025.152249_bib13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3892\/mmr.2016.5242","article-title":"Livin enhances tumorigenesis by regulating the mitogen-activated protein kinase signaling pathway in human hypopharyngeal squamous cell carcinoma","volume":"14","author":"Kim","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.acthis.2025.152249_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12951-024-02419-2","article-title":"High-performance pyrite nano-catalyst driven photothermal\/chemodynamic synergistic therapy for Osteosarcoma","volume":"22","author":"Li","year":"2024","journal-title":"J. Nanobiotechnology"},{"issue":"3","key":"10.1016\/j.acthis.2025.152249_bib15","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1006\/bbrc.2000.4027","article-title":"KIAP, a novel member of the inhibitor of apoptosis protein family","volume":"279","author":"Lin","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.acthis.2025.152249_bib16","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.3892\/ol.2015.3629","article-title":"The effects of Livin shRNA on the response to cisplatin in HepG2 cells","volume":"10","author":"Liu","year":"2015","journal-title":"Oncol. Lett."},{"issue":"12","key":"10.1016\/j.acthis.2025.152249_bib17","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1016\/j.apsb.2021.03.037","article-title":"Strategies to overcome drug resistance using SHP2 inhibitors","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"50","key":"10.1016\/j.acthis.2025.152249_bib18","doi-asserted-by":"crossref","first-page":"83502","DOI":"10.18632\/oncotarget.13148","article-title":"Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.acthis.2025.152249_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2024.100594","article-title":"BMS-794833 reduces anlotinib resistance in osteosarcoma by targeting the VEGFR\/Ras\/CDK2 pathway","volume":"45","author":"Meng","year":"2024","journal-title":"J. Bone Oncol."},{"issue":"5","key":"10.1016\/j.acthis.2025.152249_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1670","article-title":"WNT5B drives osteosarcoma stemness, chemoresistance and metastasis","volume":"14","author":"Perkins","year":"2024","journal-title":"Clin. Transl. Med"},{"issue":"16","key":"10.1016\/j.acthis.2025.152249_bib21","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1038\/sj.onc.1207515","article-title":"Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks","volume":"23","author":"Pommier","year":"2004","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.acthis.2025.152249_bib22","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/s41467-021-26343-3","article-title":"Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma","volume":"12","author":"Pu","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.acthis.2025.152249_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1097-4547(19981015)54:2<147::AID-JNR3>3.0.CO;2-E","article-title":"Ran-2, a glial lineage marker, is a GPI-anchored form of ceruloplasmin","volume":"54","author":"Salzer","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.acthis.2025.152249_bib24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fonc.2018.00004","article-title":"Osteosarcoma: accelerating progress makes for a hopeful future","volume":"8","author":"Saraf","year":"2018","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.acthis.2025.152249_bib25","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.3892\/ol.2015.3527","article-title":"Effects of siRNA Livin on EJ human bladder cancer cells treated with mitomycin-C","volume":"10","author":"Song","year":"2015","journal-title":"Oncol. Lett."},{"issue":"43","key":"10.1016\/j.acthis.2025.152249_bib26","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1038\/onc.2011.621","article-title":"Long non-coding RNAs and cancer: a new frontier of translational research?","volume":"31","author":"Spizzo","year":"2012","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.acthis.2025.152249_bib27","first-page":"4953","article-title":"Expression of Livin and PlGF in human osteosarcoma is associated with tumor progression and clinical outcome","volume":"16","author":"Sun","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.acthis.2025.152249_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbiomech.2020.110189","article-title":"Tissue engineered platforms for studying primary and metastatic neoplasm behavior in bone","volume":"115","author":"Thai","year":"2021","journal-title":"J. Biomech."},{"issue":"30","key":"10.1016\/j.acthis.2025.152249_bib29","doi-asserted-by":"crossref","first-page":"48296","DOI":"10.18632\/oncotarget.10219","article-title":"Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3","volume":"7","author":"Tu","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.acthis.2025.152249_bib30","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1166\/jnn.2019.16640","article-title":"Curcumin releasing eggshell derived carbonated apatite nanocarriers for combined anti-cancer, anti-inflammatory and bone regenerative therapy","volume":"19","author":"Verma","year":"2019","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"21","key":"10.1016\/j.acthis.2025.152249_bib31","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0960-9822(00)00781-8","article-title":"ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas","volume":"10","author":"Vucic","year":"2000","journal-title":"Curr. Biol.: CB"},{"issue":"6","key":"10.1016\/j.acthis.2025.152249_bib32","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.3892\/ol.2017.6078","article-title":"Upregulation of microRNA-143 reverses drug resistance in human breast cancer cells via inhibition of cytokine-induced apoptosis inhibitor 1","volume":"13","author":"Wang","year":"2017","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.acthis.2025.152249_bib33","first-page":"1291","article-title":"Hydrogen peroxide overload increases adriamycin-induced apoptosis of SaOS(2)FM, a manganese superoxide dismutase-overexpressing human osteosarcoma cell line","volume":"26","author":"Wang","year":"2005","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.acthis.2025.152249_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215887","article-title":"Immune checkpoints in osteosarcoma: recent advances and therapeutic potential","volume":"547","author":"Wen","year":"2022","journal-title":"Cancer Lett."},{"issue":"22","key":"10.1016\/j.acthis.2025.152249_bib35","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1200\/JCO.2003.06.001","article-title":"Overcoming drug resistance in multiple myeloma: the emergence of therapeutic approaches to induce apoptosis","volume":"21","author":"Yang","year":"2003","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.acthis.2025.152249_bib36","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.3892\/or.2017.5584","article-title":"Livin enhances chemoresistance in head and neck squamous cell carcinoma","volume":"37","author":"Yoon","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.acthis.2025.152249_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11010-008-9915-1","article-title":"The effects on cell growth and chemosensitivity by livin RNAi in non-small cell lung cancer","volume":"320","author":"Yuan","year":"2009","journal-title":"Mol. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.acthis.2025.152249_bib38","first-page":"8155","article-title":"Bioinformatics analysis and validation of mesenchymal stem cells related gene MT1G in osteosarcoma","volume":"16","author":"Zheng","year":"2024","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"10.1016\/j.acthis.2025.152249_bib39","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.21037\/tcr-19-1979","article-title":"Prognostic value of Livin in surgical specimen and biopsy in patients with osteosarcoma","volume":"9","author":"Zhou","year":"2020","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.acthis.2025.152249_bib40","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3892\/mmr.2015.3372","article-title":"Inhibition of livin expression suppresses cell proliferation and enhances chemosensitivity to cisplatin in human lung adenocarcinoma cells","volume":"12","author":"Zhuang","year":"2015","journal-title":"Mol. Med. Rep."}],"container-title":["Acta Histochemica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065128125000212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065128125000212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:00:38Z","timestamp":1762228838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065128125000212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0065128125000212"],"URL":"https:\/\/doi.org\/10.1016\/j.acthis.2025.152249","relation":{},"ISSN":["0065-1281"],"issn-type":[{"value":"0065-1281","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silencing Livin gene expression by RNA interference enhanced the chemotherapeutic sensitivity of drug-resistant osteosarcoma cells to doxorubicin","name":"articletitle","label":"Article Title"},{"value":"Acta Histochemica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acthis.2025.152249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152249"}}